ALLERGIKA GmbH

Transcription

ALLERGIKA GmbH
ALLERGIKA GmbH
COMPANY PRESENTATION
Year 2012
ALLERGIKA GmbH, Bürgermeister-Seidl-Str. 8, 82515 Wolfratshausen / Germany
www.allergika.de
CONTENTS
COMPANY PROFILE
COMPANY PROFILE
ALLERGIKA GmbH was founded as ILLA Healthcare GmbH in 1991
ALLERGIKA® dermocosmetics have been launched in 2008
Foundation
1991 as ILLA Healthcare GmbH
2009 change of the company name to ALLERGIKA GmbH
Shareholder
Hartmut Bannert
Employees
approx. 30
COMPANY PROFILE
ALLERGIKA – Success in allergy prevention and treatment for nearly 20 years
1991
Foundation as ILLA Healthcare GmbH
1995
Launch ALLERGIKA® Anti-dust mite covers
2008
Launch ALLERGIKA® dermocosmetics in Germany and Austria
2010
ALLERGIKA® trademark registration in over 50 countries
2011
Launch ALLERGIKA® dermocosmetics in Hungary & Andorra
2011
Distribution Agreement (dermocosmetics) signed with Luxembourg
(Launch March 2012)
2012
Launch of Allergika dermocosmetics & textiles in Hong Kong
2012
Other export negotiations started in many countries (dermocosmetic
& textile)
COMPANY PROFILE
The name ALLERGIKA® represents the unique ALLERGIKA® product and
marketing concept and stands for an unique concept for 30% of the population
ALLERGIKA®
Company name
ALLERGIKA®
Umbrella trademark
ALLERGIKA®
Products, indications and applications
ALLERGIKA®
Identification of patients
ALLERGIKA®
Doctors, pharmacists and customers identify ALLERGIKA
as a company specialised in allergies
COMPANY PROFILE
ALLERGIKA® is organized in two business units
 ALLERGIKA® Hair Care
 ALLERGIKA® Facial Care
 ALLERGIKA® Hand Care
8 Medical Concepts  ALLERGIKA® Body care
 ALLERGIKA® Atopic skin
 ALLERGIKA® Babies & kids
 ALLERGIKA® Sun protection
 ALLERGIKA® Foot care (to be launched in 2012)
Business Unit
DERMA:
Business Unit
TEXTILE
 ALLERGIKA® Encasings (Anti dust mite covers)
 ALLERGIKA® Travel
 ALLERGIKA® Dust mite test
 ALLERGIKA® Dust mite acaricide
 Dermifant® Neurodermatitis overalls
CONTENTS
PRODUCT PORTFOLIO
BUSINESS UNIT
DERMA
ALLERGIKA PRODUCTION & QUALITY STANDARDS
ALLERGIKA® dermocosmetics are consequently produced:







without perfumes
without preservatives
without colorants
without natural allergenes
without other allergenes listed by the German Contact Dermatitis Group
GMP pharmaceutical manufacture
Patented, airless medical packaging
Each product was tested on allergic skin with best results !
Certified by
ALLERGIKA – 8 Dermocosmetic concepts
ALLERGIKA® offers the only medical dermocosmetic concept tailormade for allergic patients from top to toe
with special products for atopic & dry skin, contact dermatitis & sun allergy.
1) Sun protection
2) Hair care
3) Facial care
4) Hand protection
5) Body care
6) Atopic, irritated & sensitive skin care
8) Skin care for kids
and babies
7) Foot care (2012)
1) Sun Protection
2) Hair Care
3) Facial Care
4) Hand Protection
5) Dry skin care
5) Dry skin care
6) Atopic, irritated & sensitive skin care
7) Foot Care
8) Skin care for kids & babies
CONTENTS
ALLERGY MARKET
ALLERGY MARKET
1. Over 30% of the population of all industrial countries are affected by
allergic diseases with an rising incidence.
2. 30% of all allergic patients suffer from skin diseases (10% of the
population). The main symptoms: Inflammation, dry and itching skin.
10% with skin
diseases!
ALLERGY MARKET
Inheritance of atopic diseases: Parents pass atopic diseases on to their
children with a risk of 70% !
This the reason why ALLERGIKA® offers a full range of dermocosmetics
including a special skin care for babies & kids from day one
(-> ALLERGIKA® Dermifant, see page 17)
One parent
is atopic
Both parents
are atopic
Both parents
are atopic with the
same symptoms
ALLERGY MARKET
Relevant indications for ALLERGIKA® dermocosmetics:
Range
Indication
EU-Market (%)
1
Itching, sensitive and irritating skin
50%*
2
Dry skin
30%**
3
Pollen allergy (itching eyes)
20%**
4
Sun allergy, Skin cancer, Sun defects
20%**
5
Eczema & Atopic dermatitis
10%**
6
Contact dermatitis
5%***
7
New born babies (sensitive, dry skin)
1%**
*Caress et al., J. Envir. Health 3/2009; Thyssen et al. Br. J. Dermat. 160, 2009
**Charité Berlin and WHO 2005
***IVDK e.V., Göttingen
CONTENTS
STRATEGY
MARKETING STRATEGY
ALLERGIKA® dermocosmetics are positioned as the only skin care concept
for damaged skin without natural and chemical allergens
Allergens based
on natural substances
Natural cosmetics for
wellness and beauty
like Weleda, Lavera
Damaged skin
Healthy skin
Common
dermocosmetics like
Louis Widmer, Avene,
La Roche-Posay,
Eucerin
Common cosmetics
for wellness and
beauty
like Vichy
Allergens based
on chemical substances
STRATEGIC OBJECTIVES
The ideal marketing partner has the following profile:

Pharmaceutical company with dermatological and/or dermocosmetic
and/or OTC business.

Sales force for dermatologists, eventual pediatricians and pharmacies.

Sales force activities to hospitals are a plus.

ALLERGIKA® dermocosmetics are complementary to the existing
product portfolio.

Enthusiasm about the ALLERGIKA® dermocosmetic concept.
STRATEGIC OBJECTIVES
ALLERGIKA® offers long-term marketing partnerships
 Exclusive marketing rights
 Use of the trademark „ALLERGIKA®“
 Product packaging in native language
 Marketing and promotional support
 International awareness
Thank you very much for your attention!
Questions?

Similar documents

Latest Report of Atopic Dermatitis Global Clinical - Classification, Prevention, Treatment and Symptoms

Latest Report of Atopic Dermatitis Global Clinical - Classification, Prevention, Treatment and Symptoms Atopic dermatitis is a common inflammatory skin condition characterized by relapsing eczematous lesions in a typical distribution. It can be frustrating for pediatric patients, parents, and health care providers alike. The pediatrician will treat the majority of children with atopic dermatitis as many patients will not have access to a pediatric medical subspecialist, such as a pediatric dermatologist or pediatric allergist. Atopic Dermatitis Global Clinical report provides up-to-date information regarding the disease and its impact, pathogenesis, treatment options, and potential complications. The goal of this report is to assist pediatricians with accurate and useful information that will improve the care of patients with atopic dermatitis.

More information